从发现研究缺口到锁定选题方向，「氢离子」如何助力中国医生的科研？
Ranking
Overall
47
Content
45
Popularity
N/A
No observed public metrics; popularity remains neutral/archived.
Merged summary
TL;DR - Alibaba Health’s medical AI platform “氢离子” now provides authorized access to full-text NEJM, JAMA Network, and BMJ content in China. It combines licensed literature with evidence-linked AI tools for clinical decision support and research workflows.
- Includes NEJM content since 1990, all published JAMA Network content, and a decade of articles from 70 BMJ journals, including figures and supplements.
- AI answers cite original passages and data, with links that let clinicians verify claims against source papers.
- Supports medically optimized bilingual reading, multi-turn clinical queries, and structured literature reviews.
- Targets workflows such as multidisciplinary case preparation, difficult-case analysis, and research evidence synthesis.
Sources (1)
从发现研究缺口到锁定选题方向，「氢离子」如何助力中国医生的科研？
Public signals
N/A
TL;DR - Alibaba Health’s medical AI platform “氢离子” now provides authorized access to full-text NEJM, JAMA Network, and BMJ content in China. It combines licensed literature with evidence-linked AI tools for clinical decision support and research workflows.
- Includes NEJM content since 1990, all published JAMA Network content, and a decade of articles from 70 BMJ journals, including figures and supplements.
- AI answers cite original passages and data, with links that let clinicians verify claims against source papers.
- Supports medically optimized bilingual reading, multi-turn clinical queries, and structured literature reviews.
- Targets workflows such as multidisciplinary case preparation, difficult-case analysis, and research evidence synthesis.